Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04805788 · ClinicalTrials.gov registry record · Phase 2
Stereotactic Body Proton Radiotherapy for the Treatment of Liver Cancer
A Phase 2 study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- Phase 2
- Development phase
- 9
- Enrollment target
NCT04805788: Clinical Trial Phase 2 study, sponsored by Mayo Clinic.
NCT04805788 is a Phase 2 study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04805788, a Phase 2 study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 9 participants
- Enrollment target
Study Summary
This phase II trial studies the effect of stereotactic body proton radiotherapy in treating patients with liver cancer. Proton radiotherapy is a type of treatment that uses high-energy beams to treat tumors.
Interventions
- OTHER Quality-of-Life Assessment
- RADIATION Proton Stereotactic Body Radiation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2021-08-24 |
| Est. Completion | 2025-01-28 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04805788
The ClinicalTrials.gov registry entry for NCT04805788 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Quality-of-Life Assessment is the first listed.
NCT04805788 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04805788 about?
NCT04805788 is a clinical study titled "Stereotactic Body Proton Radiotherapy for the Treatment of Liver Cancer". This phase II trial studies the effect of stereotactic body proton radiotherapy in treating patients with liver cancer. Proton radiotherapy is a type of treatment that uses high-energy beams to treat tumors.
What is the current status of trial NCT04805788?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 9 participants. The study started on 2021-08-24. Estimated completion is 2025-01-28.
What interventions are being tested in trial NCT04805788?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Proton Stereotactic Body Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT04805788?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.